Shandong Bailong Chuangyuan Bio-Tech's high P/E ratio is jus...
Shandong Bailong Chuangyuan Bio-Tech's high P/E ratio is justified by its strong forecast growth, surpassing the wider market. Investors' belief in low potential for earnings deterioration supports the high P/E ratio and share price.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more